A detailed history of Mairs & Power Inc transactions in Baxter International Inc stock. As of the latest transaction made, Mairs & Power Inc holds 48,767 shares of BAX stock, worth $1.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
48,767
Previous 61,308 20.46%
Holding current value
$1.6 Million
Previous $2.05 Million 9.71%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.85 - $40.26 $411,971 - $504,900
-12,541 Reduced 20.46%
48,767 $1.85 Million
Q2 2024

Aug 14, 2024

SELL
$32.87 - $43.55 $625,055 - $828,146
-19,016 Reduced 23.67%
61,308 $2.05 Million
Q1 2024

May 15, 2024

SELL
$37.88 - $43.77 $1.54 Million - $1.78 Million
-40,629 Reduced 33.59%
80,324 $3.43 Million
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $1.78 Million - $2.19 Million
-56,235 Reduced 31.74%
120,953 $4.68 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $1.66 Million - $2.19 Million
-44,377 Reduced 20.03%
177,188 $6.69 Million
Q2 2023

Aug 14, 2023

SELL
$39.98 - $47.68 $1.26 Million - $1.5 Million
-31,395 Reduced 12.41%
221,565 $10.1 Million
Q1 2023

May 15, 2023

SELL
$37.58 - $52.57 $2.68 Million - $3.75 Million
-71,340 Reduced 22.0%
252,960 $10.3 Million
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $9.69 Million - $11.2 Million
-194,887 Reduced 37.54%
324,300 $16.5 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $50,736 - $62,925
942 Added 0.18%
519,187 $28 Million
Q2 2022

Aug 15, 2022

BUY
$63.83 - $80.0 $243,639 - $305,360
3,817 Added 0.74%
518,245 $33.3 Million
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $156,774 - $182,478
-2,040 Reduced 0.39%
514,428 $39.9 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $4.44 Million - $5.19 Million
-59,496 Reduced 10.33%
516,468 $44.3 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $122,753 - $139,127
1,664 Added 0.29%
575,964 $46.3 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $416,990 - $455,891
-5,180 Reduced 0.89%
574,300 $46.2 Million
Q1 2021

May 14, 2021

SELL
$76.38 - $86.03 $1.37 Million - $1.55 Million
-17,978 Reduced 3.01%
579,480 $48.9 Million
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $377,854 - $412,788
-5,012 Reduced 0.83%
597,458 $47.9 Million
Q3 2020

Nov 16, 2020

BUY
$78.33 - $90.73 $682,489 - $790,530
8,713 Added 1.47%
602,470 $48.5 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $816,569 - $977,267
-10,381 Reduced 1.72%
593,757 $51.1 Million
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $394,207 - $513,896
-5,508 Reduced 0.9%
604,138 $49.1 Million
Q4 2019

Feb 14, 2020

SELL
$76.7 - $88.45 $215,143 - $248,102
-2,805 Reduced 0.46%
609,646 $51 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $568,497 - $627,023
-6,984 Reduced 1.13%
612,451 $53.6 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $3.33 Million - $3.74 Million
-45,362 Reduced 6.82%
619,435 $50.7 Million
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $4.03 Million - $5.08 Million
-62,512 Reduced 8.59%
664,797 $54.1 Million
Q4 2018

Feb 14, 2019

SELL
$61.45 - $77.8 $141,335 - $178,940
-2,300 Reduced 0.32%
727,309 $47.9 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $911,239 - $1 Million
-12,887 Reduced 1.74%
729,609 $56.2 Million
Q2 2018

Aug 14, 2018

SELL
$63.43 - $75.41 $4.2 Million - $4.99 Million
-66,136 Reduced 8.18%
742,496 $54.8 Million
Q1 2018

May 15, 2018

SELL
$62.56 - $72.26 $15.1 Million - $17.4 Million
-241,447 Reduced 22.99%
808,632 $52.6 Million
Q4 2017

Feb 14, 2018

SELL
$61.45 - $66.05 $7.15 Million - $7.69 Million
-116,421 Reduced 9.98%
1,050,079 $67.9 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $69.4 Million - $75.4 Million
1,166,500
1,166,500 $73.2 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Mairs & Power Inc Portfolio

Follow Mairs & Power Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.